1. Volume 52, Issue 5, Pages 1448-1455 (November 2007)
The Quality of Life and Hormonal Disturbances in Testicular Cancer Survivors in Cisplatin Era 
Paweł Wiechno, Tomasz Demkow, Krzysztof Kubiak, Małgorzata Sadowska, Janina Kamińska 
European Urology 
Volume 52, Issue 5, Pages (November 2007)
DOI: /j.eururo
Copyright © 2007 European Association of Urology Terms and Conditions

2. Fig. 1
Hormonal abnormalities among testicular cancer patients. LH=luteinizing hormone; FSH=follicle-stimulating hormone; PRL=prolactin; TSH=thyroid-stimulating hormone.
European Urology  , DOI: ( /j.eururo )
Copyright © 2007 European Association of Urology Terms and Conditions

3. Fig. 2
Mean ranks of hormone levels in testicular cancer patients and the intensity of chemotherapy. LH=luteinizing hormone; FSH=follicle-stimulating hormone.
European Urology  , DOI: ( /j.eururo )
Copyright © 2007 European Association of Urology Terms and Conditions

4. Fig. 3
The percentage of testicular cancer patients with abnormal scores in response to standardized questionnaires. STAI=State Trait Anxiety Inventory; HADS=Hospital Anxiety and Depression Scale; BDI=the Beck’s Depression Inventory; IIEF=the International Index of Erectile Function.
European Urology  , DOI: ( /j.eururo )
Copyright © 2007 European Association of Urology Terms and Conditions